嗜碱性粒细胞组胺释放试验阳性预示慢性自发性荨麻疹患者对标准剂量奥马珠单抗反应不足。 - Suppr | 超能文献

相似文献

1

Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria.嗜碱性粒细胞组胺释放试验阳性预示慢性自发性荨麻疹患者对标准剂量奥马珠单抗反应不足。

Clin Exp Allergy. 2023 Dec;53(12):1318-1321. doi: 10.1111/cea.14402. Epub 2023 Sep 28.

2

The efficacy of omalizumab treatment in chronic spontaneous urticaria is associated with basophil phenotypes.奥马珠单抗治疗慢性自发性荨麻疹的疗效与嗜碱性粒细胞表型相关。

J Allergy Clin Immunol. 2021 Jun;147(6):2271-2280.e8. doi: 10.1016/j.jaci.2021.02.038. Epub 2021 Mar 10.

3

Unique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab.对奥马珠单抗有反应的慢性自发性荨麻疹患者独特的嗜碱性粒细胞微小RNA特征。

Clin Exp Allergy. 2021 Dec;51(12):1648-1652. doi: 10.1111/cea.14014. Epub 2021 Sep 20.

4

Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.奥马珠单抗对慢性自发性荨麻疹合并多种慢性诱导性荨麻疹患者有效。

Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.

5

Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.奥马珠单抗治疗慢性自发性荨麻疹患者外周血嗜碱性粒细胞的反应。

J Allergy Clin Immunol. 2021 Jun;147(6):2295-2304.e12. doi: 10.1016/j.jaci.2021.02.039. Epub 2021 Mar 12.

6

[HOW PERIPHERAL BASOPHILS IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA ARE CHANGED WITH OMALIZUMAB TREATMENT?].[慢性自发性荨麻疹患者外周嗜碱性粒细胞经奥马珠单抗治疗后有何变化？]

Arerugi. 2021;70(9):1196-1199. doi: 10.15036/arerugi.70.1196.

7

Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.改善的 FcεRI 介导的 CD203c 嗜碱性粒细胞反应反映了奥马珠单抗对慢性自发性荨麻疹的快速反应。

J Allergy Clin Immunol Pract. 2021 Mar;9(3):1166-1176.e8. doi: 10.1016/j.jaip.2020.08.048. Epub 2020 Sep 6.

8

A very low number of circulating basophils is predictive of a poor response to omalizumab in chronic spontaneous urticaria.循环嗜碱性粒细胞数量极低预示着慢性自发性荨麻疹患者对奥马珠单抗治疗反应不佳。

Allergy. 2021 Apr;76(4):1254-1257. doi: 10.1111/all.14577. Epub 2020 Sep 17.

9

Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.奥马珠单抗对慢性荨麻疹患者嗜碱性粒细胞影响的双盲安慰剂对照试验。

Clin Exp Allergy. 2018 Feb;48(2):196-204. doi: 10.1111/cea.13066. Epub 2017 Dec 12.

10

Effect of Omalizumab on Blood Basophil Counts in Patients with Chronic Idiopathic/Spontaneous Urticaria.奥马珠单抗对慢性特发性/自发性荨麻疹患者血液嗜碱性粒细胞计数的影响。

J Invest Dermatol. 2017 Apr;137(4):958-961. doi: 10.1016/j.jid.2016.11.025. Epub 2016 Dec 6.

引用本文的文献

1

Clinical and quality of life improvement after bilastine treatment among patients with autoimmune chronic spontaneous urticaria.比拉斯汀治疗自身免疫性慢性自发性荨麻疹患者后的临床及生活质量改善情况

PLoS One. 2025 Aug 25;20(8):e0326445. doi: 10.1371/journal.pone.0326445. eCollection 2025.

2

Omalizumab pretreatment in a case of pediatric carboplatin desensitization.一例儿童卡铂脱敏治疗中的奥马珠单抗预处理。

Pediatr Allergy Immunol. 2025 Jun;36(6):e70136. doi: 10.1111/pai.70136.

3

Factors associated with quality of life of chronic spontaneous urticaria patients in a Vietnamese population.